BridgeMD
New treatment option for Healthy
Official title Integration to Improve Adolescent Health and HPV Vaccination in Laos
ClinicalTrials.gov ID: NCT06650956
What this study is testing
What is Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant?
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for healthy.
Also referred to as Gardasil.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this study is to find out if adding HPV vaccination to adolescent health services works to increase HPV vaccine uptake in 10-13-year-old girls in Laos. The study will also look at the effects of adding HPV vaccination on the use of other health services in 10-13-year-old boys and girls.
- Time commitment: about 9 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 13. Healthy volunteers may be eligible.
You may be able to join if
- Female aged 10-13 years for HPV vaccination and SRH education
- Male aged 10-13 years for SRH education
- 10-13-year-old male and female students in randomly selected schools with at least 100 students in target classes (year-5 primary, year-1, 2 and 3...
- 10-13-year-old males and females who are out-of-school and living in 2 remote villages each from four randomly selected health centers located around...
You likely can't join if
- males and females younger than 10 years or older than 13 years
The study team makes the final eligibility decision.
Where it's taking place
- Muang Sing, Province, Laos
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 9 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 13 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Muang Sing, Province, Laos. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.